Clinical Trial Update: Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating recombinant human thrombopoietin (rhTPO) for immune thrombocytopenia during pregnancy; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Recombinant human thrombopoietin (rhTPO) (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN